Biotechnology & Life Science
 |
StemCyte Inc. is a leading, global umbilical cord blood ("UCB") stem cell transplantation and therapeutic products company. StemCyte, headquartered in Southern California has UCB storage facilities in both California and in Taiwan which collect, processes and stores UCB stem cells to be used as therapeutic treatments. Stem cells are used to replace or initiate the production of other cells that are damaged or missing due to disease. | |
 |
immatics is an independent biopharmaceutical company that focuses on the development of new immunotherapeutic substances for cancer therapy. The product candidates from immatics are based upon tumor-associated peptides (TUMAPs) that specifically stimulate the immune system against cancer cells. In September 2006 – barely three years after the launch of early preclinical development – the company successfully 35 concluded an international clinical study on its product candidate IMA901 for combating renal cancer.
|
 |
Oxford Immunotec, the T cell measurement company, is headquartered near Oxford, UK. The Company develops and sells clinical diagnostic products based on its patented T-SPOT® technology, the first regulatory approved method for directly quantifying antigen-specific T cells. T-SPOT is a simple and extremely accurate method of studying a person’s cellular immune response to infection and can be applied to diagnose and monitor any major disease driven by a T cell response such as TB.
| |
 |
BMDSys develops, produces, sells and services highly innovative, non-invasive, contact-free cardiac diagnostic imaging systems using extremely high sensitive magnetic sensors. It does not expose the patient to any X-Rays, magnetic field or any other kind of energy. For an MFI-Diagnosis no contrast media has to be injected to the patient and no radioactive markers are necessary. These Magnetic Field Imaging (MFI) Systems have been primarily designed for clinical applications in cardiology. BMDSys’ leading technology provides cardiologists with reliable data about the functional condition of the human heart.
| |
 |
Luminous Medical is developing a fully automated, continuous whole blood glucose monitor for in-hospital use with critically ill patients. The system addresses the rapidly growing clinical demand for Tight Glycemic Control (TGC) in the intensive care unit, operating room, and intermediate care units. It automatically measures whole blood glucose and other analytes by optically analyzing blood as it passes through a disposable Sensor Set without any chemical interaction.
| |
 |
mtm laboratories AG is an In-Vitro Diagnostic company that develops, manufactures, and markets products for the early detection and diagnosis of cervical and other cancers. Headquartered in Heidelberg, Germany, mtm develops and manufactures its biomarker-based (IVD) proprietary products in-house and has four subsidiaries for international commercialization. | |
 |
Cardiomems has developed and is commercializing a proprietary wireless sensing and communication technology platform for the human body that is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. The Company’s miniature wireless sensors can be implanted using minimally invasive techniques to transmit real-time cardiac output, blood pressure and heart rate data to the patient's physician in order to facilitate proactive patient management and improve the patient’s quality of life.
|